|
Name |
circinophoric acid
|
Molecular Formula | C18H18O8 | |
IUPAC Name* |
2-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-6-methoxy-4-methylbenzoicacid
|
|
SMILES |
COC(=O)c1cc(O)cc(OC)c1Oc1cc(C)cc(OC)c1C(=O)O
|
|
InChI |
InChI=1S/C18H18O8/c1-9-5-12(23-2)15(17(20)21)13(6-9)26-16-11(18(22)25-4)7-10(19)8-14(16)24-3/h5-8,19H,1-4H3,(H,20,21)
|
|
InChIKey |
WNYUTRBXWKTNBF-UHFFFAOYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 362.33 | ALogp: | 3.0 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 111.5 | Aromatic Rings: | 2 |
Heavy Atoms: | 26 | QED Weighted: | 0.747 |
Caco-2 Permeability: | -5.07 | MDCK Permeability: | 0.00001170 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.017 |
Human Intestinal Absorption (HIA): | 0.142 | 20% Bioavailability (F20%): | 0.011 |
30% Bioavailability (F30%): | 0.024 |
Blood-Brain-Barrier Penetration (BBB): | 0.131 | Plasma Protein Binding (PPB): | 84.79% |
Volume Distribution (VD): | 0.462 | Fu: | 12.29% |
CYP1A2-inhibitor: | 0.214 | CYP1A2-substrate: | 0.883 |
CYP2C19-inhibitor: | 0.087 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.464 | CYP2C9-substrate: | 0.286 |
CYP2D6-inhibitor: | 0.372 | CYP2D6-substrate: | 0.175 |
CYP3A4-inhibitor: | 0.059 | CYP3A4-substrate: | 0.136 |
Clearance (CL): | 7.751 | Half-life (T1/2): | 0.856 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.147 |
Drug-inuced Liver Injury (DILI): | 0.96 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.952 | Maximum Recommended Daily Dose: | 0.311 |
Skin Sensitization: | 0.111 | Carcinogencity: | 0.016 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.175 |
Respiratory Toxicity: | 0.658 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002381 | 0.867 | D06GCK | 0.337 | ||||
ENC001490 | 0.803 | D09DHY | 0.327 | ||||
ENC001522 | 0.772 | D02LZB | 0.306 | ||||
ENC002468 | 0.691 | D0NJ3V | 0.306 | ||||
ENC005978 | 0.691 | D0E6OC | 0.305 | ||||
ENC002526 | 0.674 | D0A8FB | 0.298 | ||||
ENC005416 | 0.654 | D01FFA | 0.297 | ||||
ENC005931 | 0.624 | D0Y7TS | 0.295 | ||||
ENC006012 | 0.614 | D0AO5H | 0.293 | ||||
ENC002683 | 0.614 | D0D4HN | 0.292 |